ProShare Advisors’s Eton Pharmaceutcials ETON Stock Holding History

ProShare Advisors’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$224K	Buy	+4,342	New	+$220K	﹤0.01%	1508

Other funds holding ETON

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

ProShare Advisors's ETON Position: Q3 2026 in Review

ProShare Advisors opened a new position in Eton Pharmaceutcials (ETON) in Q3 2026: 4,342 shares worth $224K. The stake represents ﹤0.01% of the portfolio and ranks #1508 among its holdings.

91 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

ProShare Advisors held 4,342 shares of Eton Pharmaceutcials worth $224K as of Q3 2026.
Eton Pharmaceutcials was a new ProShare Advisors position in Q3 2026.
Eton Pharmaceutcials made up ﹤0.01% of ProShare Advisors's portfolio in Q3 2026, its #1508 holding.
91 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on ProShare Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.